Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4529244?pdf=render

id	doaj-5262d714c8e14e11b100fd7d595bb134
record_format	Article
spelling	doaj-5262d714c8e14e11b100fd7d595bb1342020-11-25T01:46:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013554710.1371/journal.pone.0135547Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.PLOS ONE Staffhttp://europepmc.org/articles/PMC4529244?pdf=render
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	PLOS ONE Staff
spellingShingle	PLOS ONE Staff Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients. PLoS ONE
author_facet	PLOS ONE Staff
author_sort	PLOS ONE Staff
title	Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_short	Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_full	Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_fullStr	Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_full_unstemmed	Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_sort	correction: a lead-in with silibinin prior to triple-therapy translates into favorable treatment outcomes in difficult-to-treat hiv/hepatitis c coinfected patients.
publisher	Public Library of Science (PLoS)
series	PLoS ONE
issn	1932-6203
publishDate	2015-01-01
url	http://europepmc.org/articles/PMC4529244?pdf=render
work_keys_str_mv	AT plosonestaff correctionaleadinwithsilibininpriortotripletherapytranslatesintofavorabletreatmentoutcomesindifficulttotreathivhepatitisccoinfectedpatients
_version_	1725021375262883840

Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.

Similar Items